Amyloid burden and neural function in people at risk for Alzheimer's Disease

[1]  Sterling C. Johnson,et al.  Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults , 2012, Neurology.

[2]  P. Scheltens,et al.  Brain imaging and Alzheimer's disease , 1993, European Neuropsychopharmacology.

[3]  C. Jack,et al.  An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease , 2012, Annals of neurology.

[4]  Cindee M. Madison,et al.  Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly , 2014, Human brain mapping.

[5]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[6]  John X. Morris,et al.  Increased risk of dementia in mothers of Alzheimer's disease cases , 1996, Neurology.

[7]  Gaël Chételat,et al.  Alzheimer disease: Aβ-independent processes—rethinking preclinical AD , 2013, Nature Reviews Neurology.

[8]  R. Clark,et al.  The medial temporal lobe. , 2004, Annual review of neuroscience.

[9]  Sterling C. Johnson,et al.  Effect of parental family history of Alzheimer's disease on serial position profiles , 2008, Alzheimer's & Dementia.

[10]  Rachel L. Mistur,et al.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.

[11]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[12]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[13]  J. Jolles,et al.  Functional integration of parietal lobe activity in early Alzheimer disease , 2012, Neurology.

[14]  Bedda L. Rosario,et al.  Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.

[15]  D. Balota,et al.  Role of family history for Alzheimer biomarker abnormalities in the adult children study. , 2011, Archives of neurology.

[16]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[17]  Lewis H Kuller,et al.  In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects , 2013, Annals of neurology.

[18]  R. Swerdlow,et al.  Brain aging, Alzheimer's disease, and mitochondria. , 2011, Biochimica et biophysica acta.

[19]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[21]  Rachel L. Mistur,et al.  Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease , 2009, Neurology.

[22]  C. Rowe,et al.  Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults , 2012, Neurology.

[23]  Keith A. Johnson,et al.  Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease , 2013, Neurobiology of Aging.

[24]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[25]  S. de Santi,et al.  Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s , 2010, Proceedings of the National Academy of Sciences.

[26]  J. Gunter,et al.  Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease , 2012, Neurology.

[27]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[28]  Sterling C. Johnson,et al.  White matter is altered with parental family history of Alzheimer's disease , 2010, Alzheimer's & Dementia.

[29]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[30]  Keith A. Johnson,et al.  Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals , 2013, Neurobiology of Aging.

[31]  C. Jack,et al.  Comparison of 18F-FDG and PiB PET in Cognitive Impairment , 2009, Journal of Nuclear Medicine.

[32]  M. Gatz,et al.  The Alzheimer's disease knowledge test. , 1988, The Gerontologist.

[33]  S. Vallabhajosula,et al.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents , 2013, Neurobiology of Aging.

[34]  A. Furst,et al.  Amyloid-β and glucose metabolism in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[35]  M. Albert,et al.  Medial temporal lobe function and structure in mild cognitive impairment , 2004, Annals of neurology.

[36]  C. Jack,et al.  Evidence for ordering of Alzheimer disease biomarkers. , 2011, Archives of neurology.

[37]  W. Jagust,et al.  The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.

[38]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[39]  C. Jack,et al.  Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis. , 2013, JAMA neurology.

[40]  B. Kolachana,et al.  Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults. , 2012, Archives of general psychiatry.

[41]  S. DeKosky,et al.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[43]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[44]  M. Mintun,et al.  Amyloid deposition, hypometabolism, and longitudinal cognitive decline , 2012, Annals of neurology.

[45]  Nick C. Fox,et al.  Ten simple rules for reporting voxel-based morphometry studies , 2008, NeuroImage.

[46]  B. Hermann,et al.  Middle-Aged Children of Persons With Alzheimer’s Disease: APOE Genotypes and Cognitive Function in the Wisconsin Registry for Alzheimer’s Prevention , 2005, Journal of geriatric psychiatry and neurology.

[47]  Charles A Mistretta,et al.  Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. , 2012, Medical physics.

[48]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[49]  Núria Jolis Orriols,et al.  The Alzheimer’s disease : , 2015 .

[50]  S. DeKosky,et al.  Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  Olivier Salvado,et al.  Larger temporal volume in elderly with high versus low beta-amyloid deposition. , 2010, Brain : a journal of neurology.

[52]  Francis Eustache,et al.  Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.

[53]  K. Worsley,et al.  Unified univariate and multivariate random field theory , 2004, NeuroImage.

[54]  Alan A. Wilson,et al.  Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. , 2000, Nuclear medicine and biology.

[55]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[56]  Matthew L Senjem,et al.  Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.

[57]  M. Albert,et al.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[58]  A. Hebrank,et al.  Beta-amyloid burden alters Default Mode and Salience Network connectivity related to impaired cognition in healthy adults , 2012 .

[59]  R. Honea,et al.  Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease , 2010, Neurology.

[60]  A. Fagan,et al.  APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.

[61]  Denise C. Park,et al.  &bgr;-Amyloid burden in healthy aging: Regional distribution and cognitive consequences , 2012, Neurology.

[62]  W. Jagust,et al.  Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.

[63]  Sterling C. Johnson,et al.  Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. , 2014, Cerebral cortex.

[64]  Charles A Mistretta,et al.  Dynamic PET Denoising with HYPR Processing , 2010, Journal of Nuclear Medicine.

[65]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[66]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[67]  R. Honea,et al.  Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease , 2011, Neurology.